Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

Cicin, IrfanGumus, MahmutUncu, DoganOzkan, MetinKilickap, SaadettinElkiran, Tamer E.Isikdogan, Abdurrahman2024-04-242024-04-2420170732-183X1527-7755https://doi.org/10.1200/JCO.2017.35.15_suppl.e15055https://hdl.handle.net/11468/1830053rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET -- JUN 02-07, 2017 -- Chicago, IL[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Characteristics of Turkish colorectal cancer patients and bevacizumab preference.Characteristics of Turkish colorectal cancer patients and bevacizumab preference.Conference Object35WOS:00041189570715710.1200/JCO.2017.35.15_suppl.e15055Q1